Polypeptide Multi-Target Gene Regulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current target therapy drugs are limited in their ability to address multiple diseases simultaneously, often focusing on single targets and requiring costly drug development processes.
Innovation Solution
A polypeptide with a specific amino acid sequence (SEQ ID No. 1) or its homologies, administered to regulate the expression of multiple genes and targets across various organs, effectively treating diseases related to inflammation, metabolic syndrome, obesity, muscular dystrophy, and diabetes complications by modulating key transcription factors like PPAR-γ, NF-κB, and Sirt1.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If current target therapy drugs are used to treat multiple diseases simultaneously, then treatment coverage is improved, but drug development cost and complexity increase
Solution Approach 1:
The patent applies universality by designing a single polypeptide molecule that can simultaneously target multiple transcription factors (PPAR-γ, NF-κB, and Sirt1) and regulate multiple genes across different organs. This multi-functional approach allows one drug to treat multiple diseases including inflammation, metabolic syndrome, obesity, muscular dystrophy, and diabetes complications, thereby improving treatment coverage while avoiding the need to develop separate drugs for each condition
2Ease of manufacture
If single target therapy is used, then drug development process is simplified, but therapeutic effect is limited
Solution Approach 1:
The patent overcomes the limitation of single target therapy by creating a polypeptide with multiple functional domains that can bind to and regulate multiple transcription factors simultaneously. This multi-target mechanism ensures comprehensive therapeutic effect across multiple disease pathways while maintaining a streamlined development process since it involves designing and optimizing a single polypeptide sequence rather than coordinating multiple separate drugs
3Adaptability or versatility
If multiple drugs are used to treat different diseases, then therapeutic coverage is improved, but side effects increase
Solution Approach 1:
The patent applies merging by consolidating the functions of multiple drugs into a single polypeptide molecule. By integrating multiple therapeutic activities into one agent, the patent reduces the total number of substances administered to the patient, thereby minimizing cumulative side effects while maintaining broad therapeutic coverage across multiple disease types
Data Source
AI summary
Methods for regulating multiple organs, multiple genes and multiple targets by using a polypeptide. The polypeptide includes the amino acid sequence of SEQ ID No. 1 and/or homology thereof. The polypeptide reveals the potency to regulate transcription of multiple genes and expression of multiple targets. Therefore, a composition having the polypeptide can be applied to regulate the expression of multiple targets in multiple organs of patients. Furthermore, the composition having the polypeptide can be applied in therapies of inflammation and inflammatory disorders, suppression of fatty liver disease progression, suppression of the diseases caused by fatty accumulation, prevention and therapy of muscular atrophy, and avoiding the complications of diabetes.